Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study
暂无分享，去创建一个
Xia Li | Haifeng Zhao | Jia Fan | Jian Zhou | Ti Zhang | T. Song | M. Kuang | T. Wen | Xiao-yong Huang | G. Shi | W. Gong | J. Ran | Xielin Feng | Yu Cao | Hui Zhou | H. Mou | Ying-bin Liu | Hong Zhao | T. Peng | Haiyang Zhao | Wei-Lin Wang | Yan V. Wang | Lian-Xin Liu | Guo-huan Yang | Hong-sheng Yu | Lequn Bao | Bi-Xiang Zhang | Yu-Bao Zhang | Xiang-Cheng Li | Mingxia Chen | Lian Cao | Yang Luo | Weilin Wang | Xiao-yong Huang | Bi-Xiang Zhang